WO2024090383A1 - 外因性ミトコンドリアが導入された細胞の生産方法 - Google Patents

外因性ミトコンドリアが導入された細胞の生産方法 Download PDF

Info

Publication number
WO2024090383A1
WO2024090383A1 PCT/JP2023/038203 JP2023038203W WO2024090383A1 WO 2024090383 A1 WO2024090383 A1 WO 2024090383A1 JP 2023038203 W JP2023038203 W JP 2023038203W WO 2024090383 A1 WO2024090383 A1 WO 2024090383A1
Authority
WO
WIPO (PCT)
Prior art keywords
cells
mitochondria
cell
cell culture
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2023/038203
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
浩輔 草森
元也 西川
魁人 安藤
賀一 樋上
正樹 小林
舞 金井
大成 横山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo University of Science
Original Assignee
Tokyo University of Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo University of Science filed Critical Tokyo University of Science
Priority to US19/120,533 priority Critical patent/US20260109926A1/en
Priority to JP2024553045A priority patent/JPWO2024090383A1/ja
Publication of WO2024090383A1 publication Critical patent/WO2024090383A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/20—Material Coatings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Definitions

  • the present invention relates to a method for producing cells into which exogenous mitochondria have been introduced.
  • Mitochondria are one of the intracellular organelles present in eukaryotic cells, and play an important role in adenosine triphosphate (ATP) production and apoptosis.
  • ATP adenosine triphosphate
  • Methods for introducing exogenous mitochondria into cells include (1) a method in which exogenous mitochondria are incubated with recipient cells (see, for example, Patent Document 1); (2) a method in which the surface of exogenous mitochondria is modified with a cell membrane-permeable peptide and then incubated with recipient cells (see, for example, Non-Patent Document 2); and (3) a method in which exogenous mitochondria are introduced into recipient cells by microinjection (see, for example, Patent Document 2).
  • the above method (1) is easy to operate, it has the problem of low introduction efficiency due to the negatively charged mitochondrial surface.
  • the above method (2) has a higher introduction efficiency than the above method (1), but requires time-consuming mitochondrial modification operations and there is a concern that the cells may be damaged by the cell membrane-permeable peptide, which is a cationic substance.
  • the above method (3) can reliably introduce mitochondria into recipient cells, but requires advanced techniques for operation and there is a limit to the number of recipient cells that can be targeted. Furthermore, there is a concern that the above method (3) may damage cells.
  • the present invention aims to provide a novel method for producing cells into which exogenous mitochondria have been introduced.
  • a method for producing a cell into which exogenous mitochondria have been introduced comprising the steps of: A production method comprising culturing recipient cells using a cell culture vessel having a culture surface coated with mitochondria isolated from donor cells, and allowing the mitochondria to be incorporated into the recipient cells.
  • a production method comprising culturing recipient cells using a cell culture vessel having a culture surface coated with mitochondria isolated from donor cells, and allowing the mitochondria to be incorporated into the recipient cells.
  • the cell culture equipment is a cell culture vessel or a cell culture carrier.
  • a cell into which exogenous mitochondria have been introduced the cell being produced by the production method according to ⁇ 1> or ⁇ 2>.
  • ⁇ 4> The cell according to ⁇ 3>, wherein the amount of protein of the introduced exogenous mitochondria is 0.6 ⁇ g or more per 2.0 ⁇ 10 5 cells.
  • ⁇ 5> A cell culture vessel having a culture surface coated with isolated mitochondria.
  • the cell culture substrate according to ⁇ 5> which is a cell culture vessel or a cell culture carrier.
  • a method for producing a cell culture vessel having a culture surface coated with isolated mitochondria comprising the steps of: A manufacturing method comprising adding a liquid containing isolated mitochondria to the cell culture vessel and centrifuging the cell culture vessel while the liquid contains isolated mitochondria, thereby adhering the mitochondria to the culture surface of the cell culture vessel.
  • a cell culture kit comprising a cell culture substrate and a liquid containing isolated mitochondria.
  • the present invention provides a novel method for producing cells into which exogenous mitochondria have been introduced.
  • FIG. 1 shows mitochondria attached to the inner bottom surface of a dish when mitochondria labeled with green fluorescent protein (GFP) were added to the dish and incubated for a predetermined period of time.
  • FIG. 1 shows the fluorescence intensity of the supernatant when a suspension of GFP-labeled mitochondria in phosphate-buffered saline (PBS) was centrifuged at various centrifugal forces for 10 minutes.
  • PBS phosphate-buffered saline
  • This figure shows the fluorescence intensity of the pellet suspension when GFP-labeled mitochondria were suspended in PBS and centrifuged at various centrifugal forces for 10 minutes, and the resulting mitochondrial precipitate (pellet) was resuspended in PBS.
  • FIG. 1 shows the geometric mean fluorescence intensity (gMFI) of cells cultured using a plate in which GFP-labeled mitochondria were added to the plate, followed by centrifugation and incubation for a predetermined period of time to coat the bottom surface of the wells with mitochondria, and a plate in which mitochondria were coated only by incubation without centrifugation. The cells after culture were analyzed by flow cytometry.
  • CSFE carboxyfluorescein succinimidyl ester
  • FIG. 1 shows confocal laser microscope images showing mitochondria taken up by cells when C3H10T1/2 cells were seeded on a plate coated with GFP-labeled mitochondria, and when C3H10T1/2 cells were seeded on a plate not coated with mitochondria, and then mitochondria were added to the adherent C3H10T1/2 cells.
  • FIG. 1 shows the geometric mean fluorescence intensity of cells, as determined by flow cytometry analysis of cultured C3H10T1/2 cells in two cases: when the cells were seeded onto a plate coated with GFP-labeled mitochondria, and when the cells were seeded onto a plate not coated with mitochondria and then mitochondria were added to the adherent C3H10T1/2 cells.
  • FIG. 1 shows confocal laser microscope images showing mitochondria taken up by cells when C3H10T1/2 cells were seeded on a plate coated with GFP-labeled mitochondria, and when C3H10T1/2 cells were seeded on a plate not coated with mitochondria, and then mitochondria were added to the adherent C
  • FIG. 1 shows the number of cells (relative values) after culture in the case where C3H10T1/2 cells were seeded on a mitochondria-coated plate and in the case where C3H10T1/2 cells were seeded on a non-mitochondrial-coated plate and then mitochondria were added to the adherent C3H10T1/2 cells.
  • FIG. 1 shows the amount of ATP produced by C3H10T1/2 cells when the cells were seeded on a mitochondria-coated plate.
  • FIG. 1 shows the cell numbers (relative values) after culturing C3H10T1/2 cells on plates coated with various numbers of mitochondria.
  • FIG. 1 shows the cell numbers (relative values) after culturing oligomycin-treated C3H10T1/2 cells on plates coated with various numbers of mitochondria. This figure shows in vivo imaging images when mitochondrial-introduced NanoLuc luciferase-expressing C3H10T1/2 cells or untreated NanoLuc luciferase-expressing C3H10T1/2 cells were subcutaneously administered to the back of a mouse.
  • FIG. 1 shows the luciferase activity in plasma when mitochondria-introduced NanoLuc luciferase-expressing C3H10T1/2 cells or untreated NanoLuc luciferase-expressing C3H10T1/2 cells were subcutaneously administered to the back of mice.
  • FIG. 1 shows the cell numbers (relative values) after culturing oligomycin-treated C3H10T1/2 cells on plates coated with various numbers of mitochondria. This figure shows in vivo imaging images when mitochondrial-introduced NanoLuc luciferase-expressing C3H10T1/2 cells
  • FIG. 1 shows serum AST levels when mitochondria-introduced NanoLuc luciferase-expressing C3H10T1/2 cells or untreated NanoLuc luciferase-expressing C3H10T1/2 cells were intravenously administered to carbon tetrachloride (CCl 4 )-induced liver injury model mice.
  • FIG. 13 shows serum ALT levels when mitochondria-introduced NanoLuc luciferase-expressing C3H10T1/2 cells or untreated NanoLuc luciferase-expressing C3H10T1/2 cells were intravenously administered to CCl4 -induced liver injury model mice.
  • FIG. 1 shows serum AST levels when mitochondria-introduced NanoLuc luciferase-expressing C3H10T1/2 cells or untreated NanoLuc luciferase-expressing C3H10T1/2 cells were intravenously administered to carbon tetrachloride (CCl 4 )-induced liver injury model mice.
  • FIG. 13 shows serum ALT levels when mitochondria-introduced NanoLuc lucifer
  • FIG. 1 shows the number of cells (relative values) after culture when various cells (C3H10T1/2 cells, Hepa1-6 cells, HEK293 cells, and HaCaT cells) were seeded on a mitochondria-coated plate and when various cells were seeded on a non-mitochondrial-coated plate.
  • FIG. 1 shows the amount of mitochondrial protein taken up per 2.0 ⁇ 10 5 cells when HEK293 cells were seeded on a mitochondria-coated plate and when mitochondria were added after HEK293 cells were seeded on a plate.
  • FIG. 1 shows the number of cells (relative values) after culture when various cells (C3H10T1/2 cells, Hepa1-6 cells, HEK293 cells, and HaCaT cells) were seeded on a mitochondria-coated plate and when various cells were seeded on a non-mitochondrial-coated plate.
  • FIG. 1 shows the amount of mitochondrial protein taken up per 2.0 ⁇ 10 5 cells when HEK293
  • FIG. 1 shows the amount of mitochondrial protein taken up per 2.0 ⁇ 10 5 cells when HaCaT cells were seeded on a mitochondria-coated plate and when mitochondria were added after seeding HaCaT cells on a plate.
  • FIG. 1 shows the cell numbers (relative values) after culturing C3H10T1/2 cells in the presence of various concentrations of polyethyleneimine (PEI).
  • PEI polyethyleneimine
  • the method for producing cells into which exogenous mitochondria have been introduced according to this embodiment involves culturing recipient cells using cell culture equipment whose culture surface is coated with mitochondria isolated from donor cells, and introducing the mitochondria (exogenous mitochondria) into the recipient cells.
  • Donor cells refers to cells that provide mitochondria
  • recipient cells refers to cells into which mitochondria are introduced.
  • Donor cells and recipient cells may be cells containing normal mitochondria, or cells containing dysfunctional mitochondria with mutated mitochondrial DNA.
  • cells containing dysfunctional mitochondria are used as recipient cells, at least a portion of the endogenous mitochondria may be removed in advance by a conventionally known method.
  • the biological species from which the donor cells and recipient cells are derived is not particularly limited as long as it contains mitochondria in its cells, and may be an animal or a plant.
  • biological species include mammals such as mice, rats, dogs, sheep, monkeys, and humans.
  • the donor cells and recipient cells may be derived from different individuals of the same biological species, or from different biological species.
  • the cell types of the donor cells and recipient cells are not particularly limited.
  • the donor cells and recipient cells are animal cells, examples of the cell types include muscle cells, liver cells, fibroblasts, epithelial cells, nerve cells, adipocytes, mesenchymal stem cells, etc.
  • the donor cells and recipient cells may be the same type of cells or different types of cells.
  • any method can be used to isolate mitochondria from donor cells, and a commercially available kit can be used as necessary.
  • Known methods for isolating mitochondria from donor cells include a method in which donor cells are disrupted and then the mitochondrial fraction is isolated by centrifugation, and a method in which holes are formed in the cell membrane of donor cells and then the mitochondrial fraction is isolated by centrifugation.
  • a method in which holes are formed in the cell membrane of donor cells and then the mitochondrial fraction is isolated is preferred, and in particular a method in which holes are formed in the cell membrane of donor cells using SLO and then the mitochondrial fraction is isolated (see, for example, Shibata, T. et al., Biochem. Biophys. Res. Commun., 463, 563-568, 2015).
  • a conventionally known cell culture vessel capable of culturing recipient cells can be used as the cell culture vessel for coating the isolated mitochondria.
  • the cell culture vessel include cell culture vessels such as dishes, plates, and flasks; cell culture carriers such as microcarriers; and the like.
  • the material for the cell culture vessel include glass; synthetic polymers such as polyethylene, polypropylene, and polystyrene; natural polymers such as cellulose and collagen; and metals; and the like.
  • the cell culture vessel may also be a cell culture vessel for producing cell sheets with a temperature-responsive polymer immobilized on the culture surface.
  • An example of the temperature-responsive polymer is poly(N-isopropylacrylamide).
  • the isolated mitochondria are coated onto the culture surface of the cell culture equipment.
  • the "culture surface” may be any surface that can come into contact with the recipient cells during culture, such as the inner bottom surface of a cell culture vessel or the outer surface of a cell culture carrier.
  • any method can be used to coat the isolated mitochondria onto the culture surface of the cell culture equipment, as long as it allows mitochondria to adhere to the culture surface.
  • mitochondria can be attached to the culture surface simply by leaving a liquid containing isolated mitochondria in contact with the culture surface.
  • the leaving time is preferably 12 hours or more, and more preferably 24 hours or more.
  • the liquid in which the isolated mitochondria are suspended may be a cell culture medium or a buffer solution such as PBS.
  • the mitochondria can be attached to the culture surface more efficiently and reliably by adding a liquid containing isolated mitochondria to the cell culture vessel and then centrifuging the cell culture vessel.
  • centrifugation conditions There are no particular limitations on the centrifugation conditions and they can be selected as appropriate, but examples include conditions of 300 g to 3200 g for 30 seconds to 60 minutes. After centrifugation, the cell culture vessel may be allowed to stand further with the liquid containing isolated mitochondria added.
  • the number of mitochondria to be coated on the culture surface of the cell culture equipment is appropriately set depending on the type of cell culture equipment and the number of recipient cells. As an example, it is preferable to coat the culture surface of the cell culture equipment with mitochondria isolated from donor cells whose number is 2 to 100 times the number of recipient cells.
  • the density of mitochondria to be coated on the culture surface of the cell culture equipment is preferably, for example, 5 to 15 ⁇ g/ cm2 .
  • mitochondria exogenous mitochondria
  • cell culture equipment that has been pre-coated with isolated mitochondria may be used.
  • the culture surface of the cell culture equipment may be coated with isolated mitochondria using a cell culture kit that includes a cell culture substrate and a liquid containing isolated mitochondria.
  • the cell concentration when culturing the recipient cells is not particularly limited, and may be, for example, 1.0 ⁇ 10 4 cells/mL to 5.0 ⁇ 10 5 cells/mL.
  • the conditions for culturing the recipient cells may be ordinary cell culture conditions.
  • the conditions include culturing at a temperature of 30°C to 40°C, a relative humidity of 90% to 98%, and a CO2 concentration of 3% to 7%.
  • the culture time is preferably, for example, 3 hours to 72 hours, and more preferably 6 hours to 24 hours.
  • exogenous mitochondria By introducing exogenous mitochondria into recipient cells as described above, it is possible to enrich mitochondria within the cells and improve the function, proliferation, etc. of the cells. Furthermore, by introducing normal exogenous mitochondria into recipient cells from which at least a portion of the dysfunctional endogenous mitochondria has been removed, it is possible to improve the function, proliferation, etc. of the cells.
  • the production method of the present embodiment it is possible to introduce a much larger amount of exogenous mitochondria into cells compared to a method of incubating exogenous mitochondria with recipient cells (see, for example, Patent Document 1).
  • the amount of protein of exogenous mitochondria introduced into cells by the production method of the present embodiment is, for example, 0.6 ⁇ g or more per 2.0 ⁇ 10 5 cells, preferably 0.8 ⁇ g or more, and more preferably 1.0 ⁇ g or more.
  • the production method of the present embodiment causes less damage to cells compared to a method using a cell membrane-permeable peptide that is a cationic substance (see, for example, Non-Patent Document 2) or a method using microinjection (see, for example, Patent Document 2).
  • Cells into which exogenous mitochondria have been introduced can be suitably used, for example, in cell therapy and substance production.
  • Cells into which exogenous mitochondria have been introduced tend to survive longer after transplantation, making it possible to enhance the effects of cell transplantation therapy and optimize substance production using cells.
  • Cells into which exogenous mitochondria have been introduced can also be used to produce cell sheets.
  • the obtained cell sheets can be suitably used in regenerative medicine and the like. It is also possible to directly obtain cell sheets into which exogenous mitochondria have been introduced by coating a cell culture vessel for producing cell sheets, the culture surface of which has been immobilized with a temperature-responsive polymer, with mitochondria, and then culturing recipient cells in this cell culture vessel.
  • ⁇ Preparation Example 1 Isolation of Mitochondria (SLO method)> The following two types of cells were prepared as donor cells from which mitochondria (hereinafter also referred to as "mt") were isolated.
  • C3H10T1/2 cells Mouse mesenchymal stem cells
  • 3T3-L1-mt-GFP cells Mouse fibroblast cell line expressing a fusion protein of mitochondrial cox8a signal and GFP
  • C3H10T1/2 cells or 3T3-L1-mt-GFP cells were seeded in a 15 cm dish (Thermo Fisher Scientific) at a cell number of 1.0 ⁇ 10 6 cells and cultured for 3 days. After culture, the cells were washed with PBS and collected using a trypsin/EDTA solution (2.5 g/L trypsin, 1 mmol/L EDTA). The collected cells were suspended in HEPES-CH 3 COOK buffer (480 ⁇ L) containing 1 ⁇ g/mL streptolysin O (Fujifilm Wako Pure Chemical Industries) (20 ⁇ L), incubated at room temperature for 1 to 5 minutes, and then left on ice for 10 minutes.
  • HEPES-CH 3 COOK buffer 480 ⁇ L
  • streptolysin O Flujifilm Wako Pure Chemical Industries
  • the cells were washed with Tris-sucrose buffer at 4 ° C., suspended in Tris-sucrose buffer, and incubated at 37 ° C. for 10 minutes.
  • the cell suspension was pipetted 200 times and centrifuged (400 g, 10 min, 4° C.) to collect the supernatant containing mitochondria.
  • the collected supernatant was then centrifuged (7000 g, 10 min, 4° C.) to remove the supernatant.
  • the obtained mitochondrial fraction was suspended in 15% FBS-containing DMEM medium or the like and stored at 4° C.
  • SLO method the procedure of isolating mitochondria using streptolysin O as described above is referred to as the "SLO method."
  • ⁇ Test Example 1 Adhesion of mitochondria to the bottom surface of the dish> First, mitochondria were isolated from 1.6 ⁇ 10 7 cells of 3T3-L1-mt-GFP cells using the SLO method. The mitochondrial pellet was suspended in 10% FBS-containing DMEM medium (530 ⁇ L), and the mitochondria were added to a polylysine-coated 35 mm glass bottom dish at 3.0 ⁇ 10 6 cells mt/well, and incubated for a predetermined time (1, 12, or 24 hours).
  • DAPI 4,6-diamidino-2-phenylindole
  • FIG. 1 The fluorescent image is shown in Figure 1 (scale bar: 40 ⁇ m). As can be seen from Figure 1, it was confirmed that mitochondria were attached to the inner bottom surface of the dish after approximately 12 hours of incubation.
  • mitochondria were isolated from 2.0 ⁇ 10 7 cells of 3T3-L1-mt-GFP cells using the SLO method.
  • the isolated mitochondria were suspended in PBS to 3.0 ⁇ 10 6 cells mt/300 ⁇ L, and centrifuged at various centrifugal forces (300 g, 500 g, 1000 g, 1500 g, 2000 g).
  • the temperature during centrifugation was fixed at 4° C. and the time was fixed at 10 minutes.
  • the supernatant (300 ⁇ L) after centrifugation was collected, and the mitochondrial precipitate (pellet) was resuspended in PBS (300 ⁇ L).
  • the supernatant and pellet suspensions were added to a 96-well plate (Corning) to 90 ⁇ L/well, respectively, and the fluorescence intensity was measured using a microplate reader (ARVO-MX, PerkinElmer).
  • the fluorescence intensity of the supernatant is shown in FIG. 2A
  • the fluorescence intensity of the pellet suspension is shown in FIG. 2B.
  • Each data in the figure shows the average value of three samples ⁇ standard deviation.
  • "*" in the figure indicates statistical significance ( * p ⁇ 0.05;Dunnett's test).
  • Test Example 3 Coating of mitochondria by plate centrifugation First, mitochondria were isolated from 2.0 ⁇ 10 7 cells of C3H10T1/2 cells using the SLO method. 10 ⁇ M CFSE solution (1 mL) was added to the isolated mitochondria and left on ice for 30 minutes to stain the mitochondria. After washing twice with PBS, the stained mitochondria were added to a 12-well plate at 3.0 ⁇ 10 6 cells mt/well, and the plate was centrifuged (1500 g, 10 minutes, 4° C.). Then, a fluorescent image was taken using a digital fluorescent microscope (BZ-9000, Keyence).
  • the fluorescence image is shown in Figure 3 (scale bar: 500 ⁇ m). As can be seen from Figure 3, it was confirmed that mitochondria were coated on the inner bottom surface of the wells by centrifugation of the plate for 10 minutes. Hereinafter, the operation of coating mitochondria on the inner bottom surface of the wells by centrifugation of the plate as described above will be referred to as "mt coating.”
  • ⁇ Test Example 4 Evaluation of mitochondrial uptake (FACS)> First, mitochondria were isolated from 2.0 ⁇ 10 7 cells of 3T3-L1-mt-GFP cells using the SLO method. Mitochondria were added to a 12-well plate at 3.0 ⁇ 10 6 cells mt/well, and the plate was centrifuged (1500 g, 10 minutes, 4° C.), and then incubated for 12 hours to coat the mitochondria on the inner bottom surface of the well. Next, C3H10T1/2 cells were seeded at 3.0 ⁇ 10 5 cells/well and cultured for 24 hours.
  • the cells were detached from the well using a trypsin/EDTA solution (2.5 g/L trypsin, 1 mmol/L EDTA) and suspended in PBS.
  • the suspended cells were then fixed with 4% paraformaldehyde phosphate buffer, replaced with PBS, and analyzed for mitochondrial uptake using a flow cytometer (BD FACS Lyric, Beckton Dickinson). Data were analyzed using analysis software (FlowJo software version 8.7, Beckton Dickinson).
  • Test Example 5 Evaluation of mitochondrial uptake (microscopic observation) First, mitochondria were isolated from 2.0 ⁇ 10 7 cells of 3T3-L1-mt-GFP cells using the SLO method. Mitochondria were added to a 12-well plate at 3.0 ⁇ 10 6 cells mt/well, and the plate was centrifuged (1500 g, 10 minutes, 4° C.) to coat the inner bottom surface of the well with mitochondria. Next, C3H10T1/2 cells were seeded at 3.0 ⁇ 10 5 cells/well and cultured for 24 hours.
  • the cells were detached from the well using a trypsin/EDTA solution (2.5 g/L trypsin, 1 mmol/L EDTA), seeded on a 35 mm glass bottom dish, and cultured for 12 hours.
  • the cells were then fixed in 4% paraformaldehyde in phosphate buffer, and a mounting medium containing DAPI (Vector Laboratories) was added. Fluorescent images were then taken using a confocal laser scanning microscope (SP8, Leica) and imaging software (LAS X Life Science, Leica).
  • C3H10T1/2 cells were seeded on a 12-well plate so that the cell density at the time of adding mitochondria was 3.0 ⁇ 10 5 cells/well, and cultured until the next day.
  • Mitochondria were isolated from 2.0 ⁇ 10 7 cells of 3T3-L1-mt-GFP cells using the SLO method, and the isolated mitochondria were added to the cells so that the cell density was 3.0 ⁇ 10 6 cells mt/well, and cultured for 24 hours.
  • the cells were detached from the wells using a trypsin/EDTA solution (2.5 g/L trypsin, 1 mmol/L EDTA), seeded on a 35 mm glass bottom dish, and cultured for 12 hours. Then, the adherent cells were fixed using 4% paraformaldehyde-phosphate buffer, and fluorescent images were taken in the same manner as above.
  • trypsin/EDTA solution 2.5 g/L trypsin, 1 mmol/L EDTA
  • FIG. 5 Fluorescence images are shown in Figure 5 (scale bar: 40 ⁇ m). As can be seen from Figure 5, when cells were cultured on a plate in which the inner bottom surface of the wells was coated with mitochondria, the amount of mitochondrial uptake was increased compared to when the inner bottom surface of the wells was not coated with mitochondria and mitochondria were added to adherent cells.
  • ⁇ Test Example 6 Comparison of mitochondrial uptake amount (FACS)> First, mitochondria were isolated from 3.0 ⁇ 10 7 cells of 3T3-L1-mt-GFP cells using the SLO method. Mitochondria were added to a 12-well plate at 3.0 ⁇ 10 6 cells mt/well, and the plate was centrifuged (1500 g, 10 minutes, 4° C.) to coat the inner bottom surface of the well with mitochondria. Next, C3H10T1/2 cells were seeded at 3.0 ⁇ 10 5 cells/well and cultured for 24 hours. After culture, the cells were detached from the well using a trypsin/EDTA solution (2.5 g/L trypsin, 1 mmol/L EDTA) and suspended in PBS.
  • trypsin/EDTA solution 2.5 g/L trypsin, 1 mmol/L EDTA
  • C3H10T1/2 cells were seeded on a 12-well plate so that the cell density at the time of adding mitochondria was 3.0 ⁇ 10 5 cells/well, and cultured until the next day.
  • Mitochondria were isolated from 3.0 ⁇ 10 7 cells of 3T3-L1-mt-GFP cells using the SLO method, and the isolated mitochondria were added to 3.0 ⁇ 10 6 cells mt/well and cultured for 24 hours.
  • the cells were detached from the wells using a trypsin/EDTA solution (2.5 g/L trypsin, 1 mmol/L EDTA) and suspended in PBS. Then, the floating cells were fixed using 4% paraformaldehyde-phosphate buffer, and analyzed using a flow cytometer in the same manner as above.
  • C3H10T1/2 cells were seeded in a 12-well plate so that the cell density on the next day was 3.0 x 10 5 cells/well, and cultured until the next day. Then, 15% FBS-containing DMEM medium was added instead of mitochondria, and cultured for 24 hours. After culture, the cells were detached from the wells using a trypsin/EDTA solution (2.5 g/L trypsin, 1 mmol/L EDTA) and suspended in PBS. Then, the floating cells were fixed using 4% paraformaldehyde-phosphate buffer, and analyzed using a flow cytometer in the same manner as above.
  • trypsin/EDTA solution 2.5 g/L trypsin, 1 mmol/L EDTA
  • ⁇ Test Example 7 Evaluation of proliferation of mitochondria-introduced cells> C3H10T1/2 cells (3.0 ⁇ 10 5 cells/well) were seeded on a 12-well plate coated with mitochondria derived from C3H10T1/2 cells (3.0 ⁇ 10 6 cells mt/well) and cultured for 24 hours to obtain cells into which mitochondria had been introduced.
  • a group was prepared in which mitochondria derived from C3H10T1/2 cells (3.0 ⁇ 10 5 cells/well) were added to adherent C3H10T1/2 cells (3.0 ⁇ 10 6 cells mt/well).
  • a non-treated group was prepared in which a 12-well plate not coated with mitochondria was used and 15% FBS-containing DMEM medium was added instead of mitochondria.
  • the cells prepared by each method were seeded on a 96-well plate (Corning) at 5.0 x 10 3 cells/well and cultured for 48 hours. The number of cells after culture was then measured using Cell Counting Kit-8 (CCK-8) (Fujifilm Wako Pure Chemical Industries, Ltd.). Specifically, CCK-8 solution was added at 100 ⁇ L/well and incubated for 30 minutes, after which the absorbance at a wavelength of 450 nm was measured to measure the number of cells.
  • CCK-8 Cell Counting Kit-8
  • FIG. 7 The relative cell counts of each group are shown in FIG. 7.
  • Each data in the figure shows the average value of three samples ⁇ standard deviation.
  • “ns” in the figure indicates that it is not statistically significant, and “*” indicates that it is statistically significant ( * p ⁇ 0.05;Tukey-Kramer's test).
  • FIG. 7 when cells were cultured on a plate in which the inner bottom surface of the well was coated with mitochondria, cell proliferation was significantly enhanced compared to when the inner bottom surface of the well was not coated with mitochondria and mitochondria were added to the adherent cells.
  • ⁇ Test Example 8 Evaluation of ATP production amount in mitochondria-introduced cells> C3H10T1/2 cells (3.0 ⁇ 10 5 cells/well) were seeded on a 12-well plate coated with mitochondria (3.0 ⁇ 10 6 cells mt/well) derived from C3H10T1/2 cells, and the cells were cultured for 24 hours to obtain cells into which mitochondria had been introduced. For comparison, a 12-well plate not coated with mitochondria was used to prepare an untreated group in which 15% FBS-containing DMEM medium was added instead of mitochondria.
  • the cells were detached from the wells using a trypsin/EDTA solution (2.5 g/L trypsin, 1 mmol/L EDTA), and 100 ⁇ L of the cell suspension was mixed with 100 ⁇ L of an ATP measurement reagent.
  • the mixed solution was added to a 96-well plate (Corning), and after standing for 10 minutes, the amount of luminescence derived from the cells was measured using a microplate reader (EnVision, PerkinElmer).
  • mitochondria were isolated from 2.0 ⁇ 10 7 cells of C3H10T1/2 cells using the SLO method. Mitochondria were added to a 12-well plate at a predetermined number (1.0 ⁇ 10 5 , 5.0 ⁇ 10 5 , 1.0 ⁇ 10 6 , 3.0 ⁇ 10 6 , 5.0 ⁇ 10 6 , 1.0 ⁇ 10 7 cells mt/well), and the plate was centrifuged (1500 g, 10 minutes, 4° C.) to coat the mitochondria on the inner bottom surface of the well. Next, C3H10T1/2 cells were seeded at 3.0 ⁇ 10 5 cells/well and cultured for 24 hours.
  • the cells were detached from the wells using a trypsin/EDTA solution (2.5 g/L trypsin, 1 mmol/L EDTA), seeded on a 96-well plate (Corning) at 1.0 x 10 4 cells/well, and cultured for 24 hours.
  • the number of cells after the culture was then measured using a viable cell counting kit (Cell Counting Kit-8 (CCK-8), Fujifilm Wako Pure Chemical Industries, Ltd.). Specifically, CCK-8 solution was added at 100 ⁇ L/well and incubated for 30 minutes, after which the number of cells was measured by measuring the absorbance at a wavelength of 450 nm.
  • an untreated group was also prepared, in which the same procedures as above were carried out, except that a 12-well plate without mitochondria coating was used.
  • Example 10 Evaluation of proliferation of cells treated with mitochondrial-introduced oligomycin> First, C3H10T1/2 cells were seeded in a 6-well plate at 2.0 x 105 cells/well. After 24 hours, the medium was replaced with 15% FBS-containing DMEM medium containing 10 ⁇ g/mL oligomycin. After 24 hours, the cells were harvested using a trypsin/EDTA solution (2.5 g/L trypsin, 1 mmol/L EDTA) and used as oligomycin-treated C3H10T1/2 cells in the following experiments.
  • trypsin/EDTA solution 2.5 g/L trypsin, 1 mmol/L EDTA
  • Mitochondria were isolated from 3.0 ⁇ 10 7 cells of C3H10T1/2 cells using the SLO method. Mitochondria were added to a 96-well plate (Corning) to a predetermined number (1.0 ⁇ 10 4 , 5.0 ⁇ 10 4 , 1.0 ⁇ 10 5 , 3.0 ⁇ 10 5 , 5.0 ⁇ 10 5 , 1.0 ⁇ 10 6 cells mt/well), and the plate was centrifuged (1500 g, 10 minutes, 4° C.) to coat the mitochondria on the inner bottom surface of the well. Next, oligomycin-treated C3H10T1/2 cells were seeded to 1.0 ⁇ 10 4 cells/well and cultured for 24 hours.
  • the number of cells after culture was measured using a viable cell counting kit (Cell Counting Kit-8 (CCK-8), Fujifilm Wako Pure Chemical Industries). Specifically, a CCK-8 solution was added to each well at 100 ⁇ L/well, and the mixture was incubated for 30 minutes, after which the absorbance at a wavelength of 450 nm was measured to count the number of cells.
  • Cell Counting Kit-8 (CCK-8), Fujifilm Wako Pure Chemical Industries). Specifically, a CCK-8 solution was added to each well at 100 ⁇ L/well, and the mixture was incubated for 30 minutes, after which the absorbance at a wavelength of 450 nm was measured to count the number of cells.
  • an untreated group was also prepared by carrying out the same procedures as above, except that a 96-well plate without mitochondria coating was used.
  • Test Example 11 Evaluation of survival rate after transplantation of mitochondria-introduced cells
  • NanoLuc luciferase expressing C3H10T1/2 cells (C3H10T1/2/Nluc cells) (3.0 ⁇ 10 5 cells/well) were seeded on a 12-well plate coated with mitochondria derived from C3H10T1/2 cells (3.0 ⁇ 10 6 cells mt/well) and cultured for 24 hours to obtain mitochondria-introduced C3H10T1/2/Nluc cells.
  • Mitochondria-introduced C3H10T1/2/Nluc cells (mt-C3H10T1/2/Nluc) or untreated C3H10T1/2/Nluc cells were prepared to 5.0 ⁇ 10 5 cells (200 ⁇ L) and subcutaneously administered to the back of 6-week-old male BALB/c-nu/nu mice. Then, 50 ⁇ L of luciferin (Nano-Glo, Promega) was administered to the cell administration site, and in vivo imaging was performed over time using an imaging device (In-Vivo Xtreme, Bruker Daltonik GmbH). Blood was also collected over time, and luciferase activity in plasma was measured using a microplate reader (EnVision, PerkinElmer).
  • FIG. 11A In vivo imaging images of each group are shown in FIG. 11A, and luciferase activity in plasma is shown in FIG. 11B.
  • Each data in FIG. 11B shows the average value of three samples ⁇ standard deviation.
  • "*" in FIG. 11B indicates statistical significance ( * p ⁇ 0.05;Dunnett's test).
  • the introduction of mitochondria into C3H10T1/2/Nluc cells significantly improved cell survival rate after subcutaneous transplantation into mice.
  • Test Example 12 Therapeutic effect in liver damage model mice NanoLuc luciferase expressing C3H10T1/2 cells (C3H10T1/2/Nluc cells) (3.0 ⁇ 10 5 cells/well) were seeded on a 12-well plate coated with mitochondria derived from C3H10T1/2 cells (5.0 ⁇ 10 6 cells mt/well) and cultured for 24 hours to obtain mitochondria-introduced C3H10T1/2/Nluc cells. Meanwhile, 1 mL/kg body weight of carbon tetrachloride (CCl 4 ) was intraperitoneally administered to 6-week-old male ddY mice to prepare liver injury model mice.
  • C3H10T1/2/Nluc cells C3H10T1/2/Nluc cells
  • ⁇ 10 5 cells of mitochondria-introduced C3H10T1/2/Nluc cells (mt-C3H10T1/2/Nluc) or untreated C3H10T1/2/Nluc cells were intravenously administered, and blood was collected 24 hours later.
  • serum AST and ALT levels were measured using a commercially available kit (Transaminase CII-Test Wako, Fujifilm Wako Pure Chemical Industries, Ltd.).
  • the serum AST value is shown in FIG. 12A
  • the serum ALT value is shown in FIG. 12B.
  • Each data in the figure shows the average value of three samples ⁇ standard deviation.
  • "ns" in FIG. 12B indicates that it is not statistically significant
  • "*” indicates that it is statistically significant ( * p ⁇ 0.05;Dunnett's test).
  • FIG. 12A and FIG. 12B the introduction of mitochondria into C3H10T1/2/Nluc cells showed a high therapeutic effect on liver injury model mice.
  • Mitochondria were isolated from 1.0 ⁇ 10 8 cells of C3H10T1/2 cells using the SLO method. Mitochondria were added to a 96-well plate at 1 ⁇ g/well (50 ⁇ L/well), and the plate was centrifuged (1500 g, 10 minutes, 4° C.) to coat the inner bottom surface of the well with mitochondria.
  • C3H10T1/2 cells were seeded at 1.0 ⁇ 10 3 cells/well, Hepa1-6 cells (mouse hepatoma cell line) at 2.0 ⁇ 10 3 cells/well, HEK293 cells (human fetal kidney cell line) at 2.0 ⁇ 10 3 cells/well, or HaCaT cells (human skin keratinocyte cell line) at 1.0 ⁇ 10 3 cells/well, and cultured for 48 hours. Then, the number of cells after the culture was measured using a viable cell count kit (Cell Counting Kit-8 (CCK-8), Fujifilm Wako Pure Chemical Industries, Ltd.). Specifically, CCK-8 solution was added to the wells at 100 ⁇ L/well, incubated for 30 minutes, and then the absorbance at a wavelength of 450 nm was measured to measure the number of cells.
  • CCK-8 viable cell count kit
  • CCK-8 solution was added to the wells at 100 ⁇ L/well, incubated for 30 minutes, and then the absorbance at a wavelength of 450 nm was measured
  • an untreated group was also prepared by carrying out the same procedures as above, except that a 96-well plate without mitochondria coating was used.
  • FIG. 13 The relative values of the cell counts when the average value of the cell counts in the untreated group is taken as 100% are shown in FIG. 13. Each data in the figure shows the average value of three samples ⁇ standard deviation. In addition, "*" in the figure indicates statistical significance ( * p ⁇ 0.05;Student's t-test). As can be seen from FIG. 13, cell proliferation was significantly enhanced when any of C3H10T1/2 cells, Hepa1-6 cells, HEK293 cells, and HaCaT cells was used as the recipient cells.
  • Test Example 14 Comparison of mitochondrial uptake Mitochondria were isolated from 1.2 ⁇ 10 8 cells of C3H10T1/2 cells using the SLO method, and the protein amount was measured using a protein assay kit (Pierce BCA Protein Assay Kits, Thermo Scientific). Mitochondria were added to a 12-well plate at 80 ⁇ g/well (500 ⁇ L/well), and the plate was centrifuged (1500 g, 10 minutes, 4° C.) to coat the inner bottom surface of the well with mitochondria. Next, HEK293 cells or HaCaT cells were seeded at 2.0 ⁇ 10 5 cells/well and cultured for 24 hours.
  • the mouse COX2 gene was PCR amplified using a real-time PCR analysis system (CFX Connect, Bio-Rad).
  • the PCR protocol was 95°C for 30 seconds, followed by 39 cycles of 95°C for 5 seconds, 55°C for 15 seconds, and 72°C for 45 seconds.
  • the following primers were used for PCR amplification of the mouse COX2 gene.
  • a group was prepared in which the inside bottom of the well was not coated with mitochondria, and mitochondria were added after seeding HEK293 cells or HaCaT cells, with the exception of the above-mentioned procedure.
  • the amount of mitochondrial protein taken up into HEK293 cells is shown in FIG. 14A, and the amount of mitochondrial protein taken up into HaCaT cells is shown in FIG. 14B.
  • Each data in the figure shows the average value ⁇ standard deviation of three samples.
  • "*" in the figure indicates statistical significance ( * p ⁇ 0.05;Student's t-test).
  • the amount of mitochondrial protein taken up per 2.0 ⁇ 10 5 cells was about 0.8 ⁇ g in HEK293 cells and about 1.4 ⁇ g in HaCaT cells.
  • ⁇ Test Example 15 Coating of mitochondria on a plate for preparing a cell sheet>
  • mitochondria were isolated from 2.0 ⁇ 10 7 cells of C3H10T1/2 cells using the SLO method.
  • 10 ⁇ M CFSE solution (1 mL) was added to the isolated mitochondria and left on ice for 30 minutes to stain the mitochondria.
  • the stained mitochondria were washed twice with PBS and then suspended in 15% FBS-containing DMEM medium (37° C.) (375 ⁇ L).
  • the stained mitochondria were added to a 24-well plate for cell sheet preparation (UpCell, Cell Seed) preheated to 37° C. so that the concentration of cells was 2.0 ⁇ 10 6 cells mt/well, and the plate was centrifuged (1500 g, 10 minutes, 37° C.). After washing with 15% FBS-containing DMEM medium (37° C.), the wells were observed using a digital fluorescence microscope (BZ-X800, Keyence). As a result, it was confirmed that mitochondria were attached to the inner bottom surface of the well.
  • Test Example 16 Preparation of cell sheet using mitochondria-coated plate First, mitochondria were isolated from 2.0 ⁇ 10 7 cells of C3H10T1/2 cells using the SLO method and suspended in 15% FBS-containing DMEM medium (37° C.) (375 ⁇ L). Next, the stained mitochondria were added to a 24-well plate for cell sheet preparation (UpCell, Cell Seed) pre-warmed to 37° C. so as to be 2.0 ⁇ 10 6 cells mt/well, and the plate was centrifuged (1500 g, 10 minutes, 37° C.) to coat the mitochondria on the inner bottom surface of the well.
  • FBS-containing DMEM medium 37° C.
  • C3H10T1/2 cells suspended in 15% FBS-containing DMEM medium (37° C.) were seeded to be 4.5 ⁇ 10 5 cells/well and cultured for 24 hours. After culture, the medium was removed from the plate, and 15% FBS-containing DMEM medium (50 ⁇ L) was quickly added.
  • a support Cell Shifter, CellSeed
  • the support was then peeled off from the plate and left to stand, after which 15% FBS-containing DMEM medium was dropped so that the support was immersed, and the support was peeled off using tweezers. As a result, a cell sheet into which exogenous mitochondria had been introduced could be collected.
  • Figure 16 shows the relative cell counts when the average cell count in the group without PEI was set at 100%. Each data point in the figure shows the average value ⁇ standard deviation of three samples. As previously reported (Moghimi et al., Mol. Ther., 11:990-5 (2005)), PEI showed cytotoxicity at concentrations of 10 ⁇ g/mL or higher.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Sustainable Development (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Clinical Laboratory Science (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PCT/JP2023/038203 2022-10-26 2023-10-23 外因性ミトコンドリアが導入された細胞の生産方法 Ceased WO2024090383A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US19/120,533 US20260109926A1 (en) 2022-10-26 2023-10-23 Production method of cells having exogenous mitochondria introduced thereinto
JP2024553045A JPWO2024090383A1 (https=) 2022-10-26 2023-10-23

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2022-171254 2022-10-26
JP2022171254 2022-10-26
JP2023-009196 2023-01-25
JP2023009196 2023-01-25

Publications (1)

Publication Number Publication Date
WO2024090383A1 true WO2024090383A1 (ja) 2024-05-02

Family

ID=90830768

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2023/038203 Ceased WO2024090383A1 (ja) 2022-10-26 2023-10-23 外因性ミトコンドリアが導入された細胞の生産方法

Country Status (3)

Country Link
US (1) US20260109926A1 (https=)
JP (1) JPWO2024090383A1 (https=)
WO (1) WO2024090383A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016008937A1 (en) * 2014-07-16 2016-01-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the intercellular transfer of isolated mitochondria in recipient cells
JP2017055729A (ja) * 2015-09-18 2017-03-23 国立研究開発法人科学技術振興機構 細胞内へのミトコンドリア導入方法、外因性ミトコンドリアが導入された細胞及び動物の製造方法
JP2019534031A (ja) * 2016-11-14 2019-11-28 パイアン バイオテクノロジ− インコーポレイテッド 外因性ミトコンドリアを細胞内に送達する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL282198B2 (en) * 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
JP6441472B2 (ja) * 2014-09-30 2018-12-19 台灣粒線體應用技術股▲扮▼有限公司Ｔａｉｗａｎ Ｍｉｔｏｃｈｏｎｄｒｉｏｎ Ａｐｐｌｉｅｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．，Ｌｔｄ． 活性成分として外因性ミトコンドリアを含む組成物、ならびにその使用およびそのための細胞修復法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016008937A1 (en) * 2014-07-16 2016-01-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the intercellular transfer of isolated mitochondria in recipient cells
JP2017055729A (ja) * 2015-09-18 2017-03-23 国立研究開発法人科学技術振興機構 細胞内へのミトコンドリア導入方法、外因性ミトコンドリアが導入された細胞及び動物の製造方法
JP2019534031A (ja) * 2016-11-14 2019-11-28 パイアン バイオテクノロジ− インコーポレイテッド 外因性ミトコンドリアを細胞内に送達する方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANDRES CAICEDO, VANESSA FRITZ, JEAN-MARC BRONDELLO, MICKAEL AYALA, INDIRA DENNEMONT, NAOILL ABDELLAOUI, FLORENCE DE FRAIPONT, ANAI: "MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function", SCIENTIFIC REPORTS, vol. 5, no. 1, 1 August 2015 (2015-08-01), XP055696073, DOI: 10.1038/srep09073 *

Also Published As

Publication number Publication date
JPWO2024090383A1 (https=) 2024-05-02
US20260109926A1 (en) 2026-04-23

Similar Documents

Publication Publication Date Title
Lee et al. iPSC-derived MSCs are a distinct entity of MSCs with higher therapeutic potential than their donor-matched parental MSCs
KR102675213B1 (ko) 망막 색소 표피 세포의 제조 방법
WO2011062963A2 (en) Induced puripotent stem cells and related methods
Davoodian et al. Let-7f microRNA negatively regulates hepatic differentiation of human adipose tissue-derived stem cells
WO2011102444A1 (ja) 誘導多能性幹細胞の製造方法
JP7648190B2 (ja) 成熟心筋細胞の製造法
US20250164464A1 (en) Liver organoid-derived cultured hepatocytes
Faruqu et al. Three‐dimensional culture of dental pulp pluripotent‐like stem cells (DPPSCs) enhances Nanog expression and provides a serum‐free condition for exosome isolation
KR102752280B1 (ko) 신장 전구 세포를 제조하는 방법
Giraud-Triboult et al. Combined mRNA and microRNA profiling reveals that miR-148a and miR-20b control human mesenchymal stem cell phenotype via EPAS1
EP3845639A1 (en) Method for evaluating anti-infective drugs, vaccines, etc. using immortalized monocytic cells and induced cells
EP4589004A1 (en) Production method for induced pluripotent stem cells
Kermani et al. Differentiation capacity of mouse dental pulp stem cells into osteoblasts and osteoclasts
EP3369811B1 (en) Method for producing pancreatic endocrine cells, and transdifferentiation agent
AU2017305066A1 (en) Method for inducing differentiation of pluripotent stem cells in vitro
KR101916902B1 (ko) Cd71 표면 표지인자를 마커로 하여 인간 배아줄기세포로부터 응수축성 심근세포를 제조하는 방법
Balmayor et al. Human placental alkaline phosphatase as a tracking marker for bone marrow mesenchymal stem cells
WO2024090383A1 (ja) 外因性ミトコンドリアが導入された細胞の生産方法
CN116583595A (zh) 培养构件及其用途
JP7813788B2 (ja) セクレトーム含有組成物を分析するための方法およびアッセイ
KR101546930B1 (ko) 도파민 뉴런 유사 세포군집체 및 그 제조방법
JP2010004796A (ja) 分化抑制剤、分化抑制基材及び分化抑制方法並びにその使用
KR101970642B1 (ko) 줄기세포 배양용 배지조성물 및 그를 이용한 줄기세포 배양방법
Deinsberger et al. Vascular cells differentiated from peripheral blood mononuclear cell-versus urine cell-derived induced pluripotent stem cells: A comparative analysis
Surma et al. Selection-Free Non-Viral Method Revealed Highly Efficient Crispr-Cas9 Genome Editing of Human Pluripotent Stem Cells Guided by Cellular Autophagy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23882588

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2024553045

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 23882588

Country of ref document: EP

Kind code of ref document: A1